Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

  • Log out

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
  • Log out
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review

Sara C. Keller, Pranita D. Tamma, Sara E. Cosgrove, Melissa A. Miller, Heather Sateia, Julie Szymczak, Ayse P. Gurses and Jeffrey A. Linder
The Journal of the American Board of Family Medicine May 2018, 31 (3) 417-430; DOI: https://doi.org/10.3122/jabfm.2018.03.170225
Sara C. Keller
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD, MPH, MSHP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pranita D. Tamma
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara E. Cosgrove
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa A. Miller
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Sateia
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Szymczak
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse P. Gurses
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
PhD, MS, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey A. Linder
From Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD (SCK, PDT, SEC); Division of Healthcare-Associated Infections, Agency for Healthcare Research and Quality, Rockville (MAM); Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore (HS); University of Pennsylvania Perelman School of Medicine, Philadelphia (JS); Armstrong Institute of Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore (SCK, SEC, APG); Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL (JAL).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Abstract

Introduction: In the United States, most antibiotics are prescribed in ambulatory settings. Human factors engineering, which explores interactions between people and the place where they work, has successfully improved quality of care. However, human factors engineering models have not been explored to frame what is known about ambulatory antibiotic stewardship (AS) interventions and barriers and facilitators to their implementation.

Methods: We conducted a systematic review and searched OVID MEDLINE, Embase, Scopus, Web of Science, and CINAHL to identify controlled interventions and qualitative studies of ambulatory AS and determine whether and how they incorporated principles from a human factors engineering model, the Systems Engineering Initiative for Patient Safety 2.0 model. This model describes how a work system (ambulatory clinic) contributes to a process (antibiotic prescribing) that leads to outcomes. The work system consists of 5 components, tools and technology, organization, person, tasks, and environment, within an external environment.

Results: Of 1,288 abstracts initially identified, 42 quantitative studies and 17 qualitative studies met inclusion criteria. Effective interventions focused on tools and technology (eg, clinical decision support and point-of-care testing), the person (eg, clinician education), organization (eg, audit and feedback and academic detailing), tasks (eg, delayed antibiotic prescribing), the environment (eg, commitment posters), and the external environment (media campaigns). Studies have not focused on clinic-wide approaches to AS.

Conclusions: A human factors engineering approach suggests that investigating the role of the clinic's processes or physical layout or external pressures' role in antibiotic prescribing may be a promising way to improve ambulatory AS.

  • Antibiotics
  • Antimicrobial Stewardship
  • Clinical Decision Support Systems
  • Patient Safety
  • Point-of-Care Testing
  • Quality Improvement

Antibiotic resistance is increasing worldwide, largely driven by excessive antibiotic use.1⇓–3 In the United States, antibiotic resistance contributes to 23,000 deaths annually and $20 billion in excess health care costs.4 Antibiotic stewardship (AS) minimizes the development of resistance as well as the risk of harm from antibiotic-associated adverse events by ensuring that only patients who need antibiotics get them and that each patient who needs antibiotics receives the right antibiotic at the right time at the right dose for the right duration.5

Although implementation of hospital-based AS teams have been recommended for a decade6, the majority of human antibiotic expenditures (62%) and use occurs in the ambulatory setting.7 At least 30% of these prescriptions are inappropriate.8 Reducing inappropriate ambulatory antibiotic prescribing is essential to decreasing antibiotic resistance.9,10

Human factors engineering is the “scientific discipline concerned with understanding interactions among humans and other elements of a system.”11,12 According to a health care-specific human factors engineering model, the Systems Engineering Initiative in Patient Safety (SEIPS 2.0) model,13 the characteristics of a workplace (eg, an ambulatory clinic) interact in a work system (comprised of person(s), tools and technologies, the organization, tasks, and the physical environment, within a larger external environment); this work system impacts processes such as antibiotic prescribing, which influence outcomes.13

Although human factors engineering approaches have been occasionally used in ambulatory clinics to improve patient safety and quality of care14⇓⇓⇓–18, human factors engineering approaches and models have not been applied to understanding ambulatory AS. We performed a systematic review because human factors engineering approaches describing the clinic's work system could explain influences on antibiotic prescribing and lead to more effective AS interventions. For example, human factors engineering could explain how clinic characteristics such as the ease with which clinicians adapt the electronic health record (EHR) could enhance the intervention's success. We used the SEIPS 2.0 model13 to frame what is known about effective ambulatory AS interventions and identify barriers and facilitators to successful implementation of ambulatory AS interventions.

Methods

Literature Search and Inclusion Criteria

We included quantitative studies to learn whether ambulatory AS interventions were efficacious and qualitative studies to describe barriers and facilitators to AS. We defined ambulatory settings as outpatient practices or offices in which patients came and left on their own (excluding dentistry and emergency medicine practices). We searched the OVID MEDLINE, Embase, Scopus, Web of Science, and CINAHL databases through November 7, 2016, by using a predetermined set of search terms (Appendix A). We identified additional titles from the Cochrane database as well as from the citations in identified articles. Citation titles and abstracts were screened independently by 2 reviewers (SCK and PDT), and full texts were retrieved for all potentially relevant studies. Duplicate studies were removed.

Studies were limited to English-language human studies of antibiotic-prescribing interventions or qualitative studies seeking to understand antibiotic prescribing practices. Quantitative and qualitative studies were assessed by 2 reviewers (SCK and PDT) to determine if they evaluated AS interventions conducted in ambulatory clinics. We considered AS interventions as any intervention that sought to improve the appropriate use of antibiotics in an ambulatory clinic. We included studies that measured the application of an intervention targeting antibiotic prescriptions, described the factors that influence antibiotic prescribing, or explained the process of implementing approaches to improve antibiotic prescribing. For quantitative studies, we a priori only included studies with rigorous designs: randomized controlled trials (RCTs) or quasi-experimental studies using stepped wedge or interrupted time series approaches. Qualitative studies were included if they described the context in which antibiotic prescribing decisions were made or the context, barriers, or facilitators of AS interventions. Any disagreements about study inclusion were discussed until consensus was achieved.

SEIPS 2.0 Model and Data Extraction

Data for studies meeting inclusion criteria were abstracted using components of the SEIPS 2.0 work system model.13,19 The SEIPS 2.0 work system includes 5 components within a wider external environment: (1) person(s), (2) tools and technologies, (3) organization, (4) tasks, and (5) physical environment. The work system centers around the person(s), including health care professionals, the patient and family, their individual characteristics (eg, age and education), and connections between individuals (eg, a patient-clinician relationship).13 Tools and technologies include objects that people use to do work, such as information technologies, educational materials, medical devices, testing equipment, and physical tools. Organization refers to the structures that organize clinic time, space, resources, and activities, including staff member roles. Tasks are specific actions (eg, placing an electronic order) and have qualities such as difficulty, complexity, ambiguity, variety, and sequence. The physical environment includes the clinic's physical space. The work system lies within a larger external regulatory and cultural environment, including societal, economic, and policy forces that impact a clinic.13

We used these work system components to organize aspects of the interventions and the context of AS and to understand which processes and outcomes were addressed by AS interventions. Our aim in using this approach was to identify how aspects of the clinic work system could affect AS intervention successes. We evaluated identified sources and recorded study design and aspects of the studies that could be interpreted in the context of the SEIPS 2.0 model. We also described how measures and outcomes of the studies could be interpreted in the context of the SEIPS 2.0 work system.

Results

Search Results

The search identified 1,288 abstracts (Figure 1). Four additional studies meeting inclusion criteria identified through knowledge of the literature were added based on their relevance to the work. Ultimately, 42 quantitative and 17 qualitative articles met the eligibility criteria, with 1 study considered both quantitative and qualitative.19 Fourteen of the quantitative studies were RCTs20⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–33, 1 was a randomized crossover trial34, 2 were pragmatic RCTs35,36, 14 were cluster randomized trials37⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–48, 2 were pragmatic cluster randomized trials49,50, and 9 were quasi-experimental, interrupted time series studies.19,51⇓⇓⇓⇓⇓⇓–58

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Flow chart demonstrating inclusion of articles in the review. Rigorously designed quantitative studies of ambulatory antibiotic stewardship interventions (randomized controlled trials and quasi-experimental studies with stepped wedge and interrupted time series approaches), as well as qualitative studies describing barriers and facilitators to ambulatory antibiotic stewardship were included. Databases were searched through November 7, 2016, with additional titles added based on knowledge of the literature and relevance to the work.

Of the qualitative studies, 3 were follow-up studies to prior quantitative work19,59,60 (1 of which had been described in the quantitative review).19,38 Eight studies used semistructured interviews61⇓⇓⇓⇓⇓⇓–68 and 1 used focus groups.69 One combined interviews and focus groups70 and 2 involved surveys.71,72 A single study focused on written physician self-reflection, prompting them to review the medical charts of patients.69 Finally, 1 study used a “think-aloud” approach where physicians commented on their inner thought processes.73

AS Interventions and the SEIPS 2.0 Work System

Table 1, Appendix B, and Figure 2 describe how aspects of included studies fit into components of the clinic work system.13. Appendix C describes the processes and outcomes used in each included study.

View this table:
  • View inline
  • View popup
Table 1.

Aspects of Ambulatory Antimicrobial Stewardship Interventions as Applied to Components of the Ambulatory Work System, SEIPS 2.013*

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Adaptation of the Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 model of the health care work system to approaches taken in the literature to improve antibiotic stewardship in the ambulatory setting.

Tools and Technology

Tools and technologies include objects and technologies that people use to do work. AS interventions incorporating tools and technologies included clinical decision support systems (CDSS), interventions based in EHRs, educational tools (eg, newsletters, booklets, and videotapes), AS messaging tools (eg, magnets and lapel pins), and point-of-care (POC) testing.

CDSS tools and other EHR-based interventions were frequent and often effective. Highlighting several CDSS tools, a CDSS incorporated into an EHR encounter template decreased acute respiratory infection (ARI) antibiotic prescriptions from 43% to 38% (versus 40% to 39% in control groups).41 An RCT of a computerized patient flow manager with evidence-based prompts decreased antibiotic prescriptions for acute otitis media by 34%.32,74

EHR-based tools have incorporated behavioral interventions. In a 2 × 2 × 2 randomized factorial study comparing accountable justification (providing a written explanation for prescribing nonindicated antibiotics) and suggested alternatives (pop-up messages with education and nonantibiotic alternatives), the suggested alternatives arm was associated with decreased antibiotic prescriptions for ARIs.20 In a larger cluster randomized trial, suggested alternatives did not decrease antibiotic prescription, but accountable justification decreased inappropriate antibiotic prescribing (23% to 5%).43

However, the context in which electronic tools were deployed impacted their implementation. Factors associated with unsuccessful incorporation of CDSS tools and EHR technologies into clinics included nonintuitive tools, need for additional software,51 computers not being available in examination rooms, and slow internet connectivity.19 CDSS tools needed to be used to have an effect; in a cluster randomized trial, EHR-integrated CDSS did not impact antibiotic prescribing, but the CDSS tool was used in only 6% of intervention clinic visits.75

The effect of educational tools was mixed. Educational booklets (eg, on self-care for respiratory infections, potential harms of antibiotics, and other topics) were developed with the goals of assisting patients with understanding harms associated with unnecessary antibiotic use and supporting clinicians with antibiotic prescribing.59,66 As a broader intervention including physician feedback, mailing brochures to parents of children successfully decreased community-wide antibiotic use by 4.6% among those aged 2 to 4 years and by 6.7% among those aged 4 to 5 years.42 However, in another study involving mailed patient and clinician education, antibiotic use did not decrease.55 In addition, in a trial of patient educational materials including a letter from the medical director along with pamphlets compared materials mailed to patients and to office practices, pamphlets mailed to offices only, and usual care on antibiotic prescription for acute bronchitis.56 Only the full intervention sites showed a decline in antibiotic prescriptions for acute bronchitis visits, from 74% to 48%.56

Evidence was similarly mixed regarding the impact of multifaceted educational tool bundles. In a cluster randomized trial in 16 Massachusetts communities, clinicians were given tools with AS messages (ie, stickers, lapel pins, and otoscope insufflators), bimonthly newsletters regarding AS, and prescription pads with written recommendations for symptomatic treatment of viral ARIs.46,53 Parents of young children were also mailed brochures and advertisements were placed in child care centers and pharmacies.46 Although there was no difference in ARI antibiotic prescribing in children <2 years, a 5% decrease in children 2 to 3 years and a 7% decrease in children 4 to 5 years was observed.46 In an additional cluster randomized trial, a multifaceted intervention (educational information at pharmacies and clinics, patient mailings, clinic posters, refrigerator magnets, flip charts, patient-initiated chart documentation tools, and CDSS tools) resulted in a decrease in antibiotic prescriptions among children <6 years.37 Another multifaceted intervention (CDSS, clinician education, audit and feedback, and patient education brochures) also led to decreases in the percentage of adolescents and adults prescribed antibiotics for ARIs at CDSS sites (decreased 12%) versus control sites (increased 1%), with no impact on 30-day return visits.40

Interventions involving tools for patient and family education were not always successful. An intervention including mailed information and guideline distribution did not decrease antibiotic use among elderly patients with ARIs.57 Meanwhile, providing patients with an educational pamphlet and videotape of their pediatricians did not decrease the number of viral ARI visits, antibiotic prescriptions for acute otitis media or sinusitis, or total antibiotic prescriptions.27 Patient characteristics such as older age and the need to open the pamphlet or view the videotapes may have made these interventions less effective.

Other studies focused on POC testing as a tool. C-reactive protein (CRP) POC testing may perform better than clinical symptoms and signs in predicting the diagnosis of pneumonia52, but decreases clinician confidence in reducing antibiotic prescribing and decreases patient satisfaction.59 In a study of POC CRP testing availability, antibiotic prescription improved49, but on follow-up 2 to 3 years later, POC CRP testing was only performed in 4% of eligible patient visits.50 POC tests have also been criticized for their short shelf life, need for quality control testing, and difficulties linking the test result to the EHR.76 These factors may have made the tools more difficult to incorporate into practice and limited their effectiveness.

Person

The person component of the SEIPS 2.0 work system describes individual characteristics and relationships between individuals. However, characteristics and perspectives of other clinic staff members such as medical assistants, nurses, and front desk staff were not described.

Patients and Families

Patient factors such as symptoms and comorbidities influence whether a clinician would prescribe antibiotics.19,61,66 Patient and family factors such as education, knowledge of antibiotics, or trust in their physician decreased requests for antibiotics.35,67,71

Clinicians

Clinician training, particularly focusing on communication training, problem-solving strategies, and peer review, was also studied. In an RCT, French general practitioners were randomized to a day-long seminar focusing on problem-solving strategies after all attended a 2-day seminar on evidence-based ARI management.29 The intervention group sustained a decrease in the proportion of antibiotics prescribed over 30 months.29 General practitioners who attended a training session or received in-office instruction along with clinician-specific feedback increased adherence to community-acquired pneumonia guidelines.45 A workshop including peer reviews of transcripts of interactions with standardized patients reduced antibiotic prescriptions from 54% to 27%,49 sustained for 2 to 3 years.50

Clinician and Patient Relationships

Relationships between individuals are an important part of the ambulatory work system.13 Some physicians think that patients want antibiotics61 and prescribe antibiotics to meet perceived patient expectations.68 Physicians may also believe that patients want something (ie, an antibiotic prescription) in exchange for taking off work and paying copays.63

Organization

The organization refers to the structures and roles that organize a clinic. Characteristics of the clinic, roles of clinic members, and the larger organizations in which clinics operate were explored through investigating roles of clinic team members, comparing clinicians to peers, and learning how clinic structures allow clinician education or improve communication.

Few studies involved changing roles of nonclinician staff members to impact AS. Only 1 study included a nonclinician staff member in an educational intervention and the role of this person was not specified.51 In a qualitative study, clinicians suggested using nurses to perform previsit triage and education.72 In POC testing interventions, participants found that it was unclear which staff members to train in POC testing, as various organizational roles performed the test in different clinics.76,77

Audit and feedback interventions, where clinicians are compared with others, have had success.20,48 In a Canadian RCT where clinicians were mailed educational information or prescribing feedback, the feedback group was more likely to use first-line antibiotic prescriptions.21 In a cluster randomized trial, comparing clinicians with top performers (those who seldom prescribe antibiotics inappropriately) decreased inappropriate prescriptions from 20% to 4%.43 In an RCT, antibiotic use decreased among providers who received a letter from England's chief medical officer saying they were prescribing more antibiotics than 80% of local practices.22 An RCT found that the combination of clinician education and audit and feedback decreased antibiotic prescribing overall and broad-spectrum prescribing in particular.38

However, audit and feedback may not be universally successful. In the above RCT,38 after the termination of audit and feedback, prescribing of broad-spectrum antibiotics returned to a level above baseline.39 In a follow-up qualitative study, some clinicians expressed skepticism and discounted the reports.60 Furthermore, in a recent RCT of high-prescribing physicians across Switzerland, receiving letters and an online log-in code with information about antibiotic prescribing did not impact antibiotic prescribing over 2 years.36 Only 11% of physicians in the intervention group viewed their prescribing data.36 Similarly, a cluster randomized trial of an audit and feedback dashboard led to no difference in antibiotic prescribing for ARI visits78, but only 28% of intervention-group physicians used the dashboard. These clinicians had a lower ARI antibiotic prescribing rate (42% versus 50%).78

Organizational structures could pose barriers to AS. Clinic visits were often too brief to discuss guidelines with patients.63,70 If patients saw multiple clinicians in a practice with different prescribing practices, patients may have expected to receive antibiotics.63,70 Many clinics did not have protected time for group education.63 However, in practices where physicians discussed AS guidelines, outcomes improved.52,46

If clinics had protected time for group education, academic detailing, where an expert visits a practice to discuss AS,51,64 was successful.55 In a study comparing (1) office-based patient education, (2) office- and home-based patient and clinician education (practice profiling, setting clinic goals, and academic detailing), and (3) usual care, full intervention sites had a substantial decline in antibiotic prescriptions for acute bronchitis (74% to 48%), whereas the control and limited intervention sites did not.56

Tasks

Tasks describe specific actions and their characteristics. Clinicians pick particular words when describing physical examination findings to patients or perform a thorough physical examination to explain to patients why they were not prescribing antibiotics.61,66,73

In delayed prescription strategies, the clinician gives the patient a prescription and leaves it up to the patient whether to fill it after a specified time or with worsened symptoms. Patients with acute uncomplicated ARIs were randomized: (1) deciding to fill the prescription after 2 days, (2) returning to the clinic after 2 days for a prescription, (3) no prescription, or (4) immediate prescription.35 Patient satisfaction was similar in all groups, and antibiotic use and belief in antibiotic effectiveness was lower in all groups compared with the immediate prescription group.35

Physical Environment

The physical environment refers to the clinic's layout. Most physical environment-based interventions used posters.24,38,46,59,60 By themselves, posters about avoiding antibiotics for “chest colds” did not decrease antibiotic prescription for acute bronchitis.56 However, visible signed commitments about avoiding unnecessary antibiotics decreased unnecessary antibiotic prescribing by up to 20%.31 Studies did not discuss optimizing the placement of these posters.37,45,46,53,56,57

External Environment

The larger external environment includes guidelines and societal, economic, and policy forces that impact a clinic. External guidelines were not always used because they were sometimes difficult to locate63,64,69, too long64, or not seen as relevant.64 Some physicians did not trust guidelines, wondering whether they were intended to save money instead of improving care.64

Media campaigns reinforced what clinicians conveyed.66 A Colorado-wide campaign of billboards, bus signs, radio advertisements, and newspaper op-eds decreased population-wide antibiotic dispenses.53,57 Advertisements in child care centers and pharmacies also reduced antibiotic use.46 In another community-level study, interventions including news releases, community meetings, and presentations at health fairs decreased antibiotic prescriptions.37 In an Italian study, region-wide campaign materials (posters, brochures, and local media advertisements) and a doctor and pharmacist newsletter decreased antibiotic prescribing by 4%.58

Discussion

Human factors engineering approaches have only recently been used in ambulatory clinics to describe defects in testing,14 apply new EHR technologies15,18, and improve clinic workflows.16,17 Our review is the first to incorporate a human factors engineering approach to understanding ambulatory AS.

In the SEIPS 2.0 work system, tools and technologies refer to objects and technologies. Tools and technologies used in ambulatory AS interventions have included CDSS and EHR-based interventions, educational materials, and POC testing. CDSS and EHR-based and educational materials improved AS but only if they were used. POC tools such as CRP testing impacted AS, but many clinicians stopped using the POC tests over time. Human factors engineering would suggest that to make these tools more effective, researchers should make them easier to use.

The person component of the work system includes individual characteristics and relationships between individuals. In particular, clinician communication training had a sustained positive impact on AS, and interventions aimed at educating patients and families also showed a positive impact on AS. However, although clinicians have mentioned the potential impact of other members of the health care team, characteristics of other health care team members have not been studied. Human factors engineering would suggest that the role of other members of the health care team in AS interventions should be studied and these team members should be engaged.

Few studies focused on the organization component of the work system model or the structures and roles that organize a clinic. Audit and feedback and academic detailing had a positive impact on AS. However, we know little about the role of nonclinicians in AS. Engagement of the entire ambulatory team has the potential to send a consistent message about appropriate antibiotic prescribing.68 Human factors engineering would suggest research exploring the roles of clinic staff and clinic flow in an intervention's effectiveness.

Similarly, few interventions focused on the work system component of tasks or specific actions and their characteristics, although delayed prescription strategies were promising. Few interventions focused on the impact of the physical environment of the clinic on antibiotic prescription. However, clinic posters with signed commitments advocating AS positively impacted AS. Human factors engineering would suggest an investigation into the role of the location of clinic posters and other elements of the physical environment, as well as qualities of tasks related to antibiotic prescription, on AS interventions.

Finally, the work system occurs within the external regulatory and cultural environment. Several interventions incorporated the external environment, showing that media-based interventions could improve AS at a community level and showing that external guidelines needed to be accessible to clinicians and trusted by clinicians. The role of the external environment in the form of external pressures on AS interventions such as patient satisfaction-based reimbursement has not been fully examined and should be a focus of future research.

Our review has several limitations. We only included well-controlled quantitative studies and may have missed other domains if they were targeted only in uncontrolled studies. We did not assess for publication bias. Finally, our findings are more applicable to ARIs, the focus of most studies, as we were unable to identify many high-quality studies that implemented AS for other conditions (eg, urinary tract infections and cellulitis).

Evidence-based AS interventions impact different portions of the ambulatory work system, and using a human factors engineering approach may facilitate the intervention's success. However, interventions did not typically engage all clinic staff in the implementation, a model that has led to successes in patient safety and quality improvement.79⇓⇓⇓⇓–84 Few interventions have accounted for physical environment or task characteristics in implementing interventions. Future work in ambulatory AS should address the entire work system in which the intervention is implemented. Such work system interventions, if rigorously evaluated, may have greater potential than isolated interventions to improve the effectiveness of ambulatory AS.

Acknowledgments

We gratefully acknowledge the support of Maria Trusky, MLS, for her assistance in extracting the articles. We also appreciate the assistance of Kathleen Speck, MPH, for assistance in formatting the tables.

Appendix A: Search Terms

PubMed 341 Results, 11/7/2016

(“Anti-Infective Agents”[Mesh] OR “Anti Infective Agents” OR “Anti Infective Agent” OR “Antiinfective Agents” OR “Antiinfective Agent” OR “Anti-infective agents” OR “anti-infective agent” OR “Microbicides” OR “antimicrobial agents” OR “antimicrobial agent” OR “antimicrobials” OR “Anti-Microbial Agents” OR “antimicrobial agent” OR “Anti Microbial Agents” OR “anti microbial agent” OR “antibiotics” OR “antibiotic” OR “antibiotics” OR “antibiotic” OR “Anti Bacterial Agents” OR “Anti Bacterial Agent” OR “Antibacterial Agents” OR “Antibacterial Agent” OR “Bacteriocidal Agents” OR “Bacteriocides” OR “Anti-Mycobacterial Agents” OR “Anti Mycobacterial Agents” OR “Antimycobacterial Agents”) AND (“stewardship” OR “stewards” OR “antimicrobial management” OR “antimicrobial prescribing behavior” OR “antibiotic stewardship” OR “antimicrobial stewardship” OR “appropriate use” OR “Drug Utilization”[Mesh] OR “ASP”) AND (“Ambulatory Care”[Mesh] OR “ambulatory care” OR “ambulatory health services” OR “outpatient care” OR “outpatient health services” OR “outpatient health service” OR “urgent care” OR “urgent cares”).

Embase 321 Results, 11/7/2016

(“antiinfective agent”/exp OR “anti infective agent*” OR “antiinfective agent*” OR “anti-infective agent*” OR “microbicide*” OR “antimicrobial*” OR “antimicrobial agent*” OR “anti microbial agent*” OR “antibiotic*” OR “antibiotic*” OR “anti bacterial agent*” OR “antibacterial agent*” OR “bacteriocidal agent*” OR “bacteriocide*” OR “antimycobacterial agent*” OR “anti mycobacterial agent*”) AND (“drug utilization”/exp OR “drug utilization” OR “drug utilization” OR “stewardship” OR “stewards” OR “antimicrobial management” OR “antimicrobial prescribing behavior” OR “antibiotic stewardship” OR “antimicrobial stewardship” OR “appropriate use” OR “asp”) AND (“ambulatory care”/exp OR “ambulatory care” OR “ambulatory health service*” OR “outpatient care*” OR “outpatient health service*” OR “urgent care*” OR “dispensary care” OR “extramural care”).

Scopus 525 Results, 11/7/2016

(TITLE-ABS-KEY (“antiinfective agent*” OR “anti infective agent*” OR “anti-infective agent*” OR “microbicide*” OR “antimicrobial*” OR “antimicrobial agent*” OR “anti microbial agent*” OR “antibiotic*” OR “antibiotic*” OR “anti bacterial agent*” OR “antibacterial agent*” OR “bacteriocidal agent*” OR “bacteriocide*” OR “antimycobacterial agent*” OR “anti mycobacterial agent*”)) AND (TITLE-ABS-KEY (“stewardship” OR “stewards” OR “antimicrobial management” OR “antimicrobial prescribing behavior” OR “antibiotic stewardship” OR “antimicrobial stewardship” OR “appropriate use” OR “Drug Utilization” OR “drug utilization” OR “ASP”)) AND (TITLE-ABS-KEY (“ambulatory care*” OR “ambulatory health service*” OR “outpatient care*” OR “outpatient health service*” OR “urgent care*” OR “dispensary care” OR “extramural care”)).

Web of Science 37 Results, 11/7/2016

TS = (“antiinfective agent*” OR “anti infective agent*” OR “anti-infective agent*” OR “microbicide*” OR “antimicrobial*” OR “antimicrobial agent*” OR “anti microbial agent*” OR “antibiotic*” OR “antibiotic*” OR “anti bacterial agent*” OR “antibacterial agent*” OR “bacteriocidal agent*” OR “bacteriocide*” OR “antimycobacterial agent*” OR “anti mycobacterial agent*”) AND TS = (“stewardship” OR “stewards” OR “antimicrobial management” OR “antimicrobial prescribing behavior” OR “antibiotic stewardship” OR “antimicrobial stewardship” OR “appropriate use” OR “Drug Utilization” OR “drug utilization” OR “ASP”) AND TS = (“ambulatory care*” OR “ambulatory health service*” OR “outpatient care*” OR “outpatient health service*” OR “urgent care*” OR “dispensary care” OR “extramural care”).

CINAHL 64 Results, 11/7/2016

((MH “Antiinfective Agents+”) OR “antiinfective agent*” OR “anti infective agent*” OR “anti-infective agent*” OR “microbicide*” OR “antimicrobial*” OR “antimicrobial agent*” OR “anti microbial agent*” OR “antibiotic*” OR “antibiotic*” OR “anti bacterial agent*” OR “antibacterial agent*” OR “bacteriocidal agent*” OR “bacteriocide*” OR “antimycobacterial agent*” OR “anti mycobacterial agent*”) AND ((MH “Drug Utilization”) OR “stewardship” OR “stewards” OR “antimicrobial management” OR “antimicrobial prescribing behavior” OR “antibiotic stewardship” OR “antimicrobial stewardship” OR “appropriate use” OR “drug utilization” OR “ASP”) AND ((MH “Ambulatory Care”) OR “ambulatory health service*” OR “outpatient care*” OR “outpatient health service*” OR “urgent care*” OR “dispensary care” OR “extramural care”).

Appendix

View this table:
  • View inline
  • View popup
Appendix B:

Aspects of Ambulatory Antimicrobial Stewardship Interventions as Applied to Components of the Ambulatory Work System (SEIPS 2.0).13*

Appendix

View this table:
  • View inline
  • View popup
Appendix C.

Summary of the Impact of Ambulatory Antimicrobial Stewardship Interventions*

Notes

  • This article was externally peer reviewed.

  • Funding: This work was supported by the Agency for Healthcare Research and Quality (AHRQ) (HHSP233201500020I/HHSP23337003T). The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. SCK received funding from the National Center for Advancing Translational Sciences/Johns Hopkins Institute for Clinical and Translational research, KL2 award KL2TR001077.

  • Conflict of interest: none declared.

  • To see this article online, please go to: http://jabfm.org/content/31/3/417.full.

  • * An asterisk indicates that a word stem was used as a search term (for example, antibiotic* signified that either “antibiotic” or “antibiotics” was searched for).

  • Received for publication June 7, 2017.
  • Revision received December 28, 2017.
  • Accepted for publication January 4, 2018.

References

  1. 1.
    1. Pakyz A,
    2. Powell JP,
    3. Harpe SE,
    4. Johnson C,
    5. Edmond M,
    6. Polk RE
    . Diversity of antimicrobial use and resistance in 42 hospitals in the United States. Pharmacotherapy 2008;28:906–12.
  2. 2.
    1. Pakyz AL,
    2. MacDougall C,
    3. Oinonen M,
    4. Polk RE
    . Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008;168:2254–60.
  3. 3.
    1. Adriaenssens N,
    2. Coenen S,
    3. Muller A,
    4. Vankerckhoven V,
    5. Goossens H,
    6. Group EP
    . European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe. J Antimicrob Chemother 2010;65:769–74.
  4. 4.
    Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed on September 28, 2017.
  5. 5.
    The White House. National Action Plan for Combating Antibiotic-Resistant Bacteria. 2015. Available at: https://obamawhitehouse.archives.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf. Accessed April 16, 2018.
  6. 6.
    1. Dellit TH,
    2. Owens RC,
    3. McGowan JE Jr..,
    4. et al
    . Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–77.
  7. 7.
    1. Suda KJ,
    2. Hicks LA,
    3. Roberts RM,
    4. Hunkler RJ,
    5. Danziger LH
    . A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother 2013;68:715–8.
  8. 8.
    1. Fleming-Dutra KE,
    2. Hersh AL,
    3. Shapiro DJ,
    4. et al
    . Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA 2016;315:1864–73.
  9. 9.
    1. Nicolle LE,
    2. Bradley S,
    3. Colgan R,
    4. et al
    . Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643–54.
  10. 10.
    1. Chow AW,
    2. Benninger MS,
    3. Brook I,
    4. et al
    . IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012;54(8):e72–e112.
  11. 11.
    1. Gurses AP,
    2. Ozok AA,
    3. Pronovost PJ
    . Time to accelerate integration of human factors and ergonomics in patient safety. BMJ Qual Saf 2012;21:347–51.
  12. 12.
    International Ergonomics Association. Definition and domains of ergonomics. 2017. Available from: http://www.iea.cc/whats/. Accessed on September 28 2017.
  13. 13.
    1. Holden RJ,
    2. Carayon P,
    3. Gurses AP,
    4. et al
    . SEIPS 2.0: a human factors framework for studying and improving the work of healthcare professionals and patients. Ergonomics 2013;56:1669–86.
  14. 14.
    1. Henriksen K,
    2. Battles JB,
    3. Keyes MA,
    4. Grady ML
    1. Elder NC,
    2. McEwen TR,
    3. Flach JM,
    4. Gallimore JJ
    . Creating safety in the testing process in primary care offices. In: Henriksen K, Battles JB, Keyes MA, Grady ML, eds. Advances in patient safety: new directions and alternative approaches (Vol 2: Culture and redesign). Rockville, MD: Agency for Healthcare Research and Quality; 2008.
  15. 15.
    1. Asan O
    . Providers' perceived facilitators and barriers to EHR screen sharing in outpatient settings. Appl Ergon 2017;58:301–7.
  16. 16.
    1. Patterson ES,
    2. Lowry SZ,
    3. Ramaiah M,
    4. et al
    . Improving clinical workflow in ambulatory care: implemented recommendations in an innovation prototype for the Veteran's Health Administration. EGEMS (Wash DC) 2015;3:1149.
  17. 17.
    1. Saleem JJ,
    2. Adams S,
    3. Frankel RM,
    4. Doebbeling BN,
    5. Patterson ES
    . Efficiency strategies for facilitating computerized clinical documentation in ambulatory care. Stud Health Technol Inform 2013;192:13–7.
  18. 18.
    1. van Stiphout F,
    2. Zwart-van Rijkom JE,
    3. Maggio LA,
    4. et al
    . Task analysis of information technology-mediated medication management in outpatient care. Br J Clin Pharmacol 2015;80:415–24.
  19. 19.
    1. Donabedian A
    . The quality of care. How can it be assessed? JAMA 1988;260:1743–8.
  20. 20.
    1. Litvin CB,
    2. Ornstein SM,
    3. Wessell AM,
    4. Nemeth LS,
    5. Nietert PJ
    . Adoption of a clinical decision support system to promote judicious use of antibiotics for acute respiratory infections in primary care. Int J Med Inform 2012;81:521–6.
  21. 21.
    1. Persell SD,
    2. Doctor JN,
    3. Friedberg MW,
    4. et al
    . Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC Infect Dis 2016;16:373.
  22. 22.
    1. Hux JE,
    2. Melady MP,
    3. DeBoer D
    . Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial. CMAJ 1999;161:388–92.
  23. 23.
    1. Hallsworth M,
    2. Chadborn T,
    3. Sallis A,
    4. et al
    . Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016;387:1743–52.
  24. 24.
    1. Strykowski DF,
    2. Nielsen AB,
    3. Llor C,
    4. Siersma V,
    5. Bjerrum L
    . An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD. Fam Pract 2015;32:395–400.
  25. 25.
    1. Foxman B,
    2. Valdez RB,
    3. Lohr KN,
    4. Goldberg GA,
    5. Newhouse JP,
    6. Brook RH
    . The effect of cost sharing on the use of antibiotics in ambulatory care: results from a population-based randomized controlled trial. J Chronic Dis 1987;40:429–37.
  26. 26.
    1. Long W,
    2. Deng X,
    3. Zhang Y,
    4. Lu G,
    5. Xie J,
    6. Tang J
    . Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology 2011;16:819–24.
  27. 27.
    1. Arakaki RY,
    2. Strazzula L,
    3. Woo E,
    4. Kroshinsky D
    . The impact of dermatology consultation on diagnostic accuracy and antibiotic use among patients with suspected cellulitis seen at outpatient internal medicine offices: a randomized clinical trial. JAMA Dermatol 2014;150:1056–61.
  28. 28.
    1. Taylor JA,
    2. Kwan-Gett TS,
    3. McMahon EM Jr.
    . Effectiveness of a parental educational intervention in reducing antibiotic use in children: a randomized controlled trial. Pediatr Infect Dis J. 2005;24:489–93.
  29. 29.
    1. Torres FA,
    2. Pasarelli I,
    3. Cutri A,
    4. Ossorio MF,
    5. Ferrero F
    . Impact assessment of a decision rule for using antibiotics in pneumonia: a randomized trial. Pediatr Pulmonol 2014;49:701–6.
  30. 30.
    1. Le Corvoisier P,
    2. Renard V,
    3. Roudot-Thoraval F,
    4. et al
    . Long-term effects of an educational seminar on antibiotic prescribing by GPs: a randomised controlled trial. Br J Gen Pract 2013;63:e455–64.
  31. 31.
    1. Meeker D,
    2. Knight TK,
    3. Friedberg MW,
    4. et al
    . Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med 2014;174:425–31.
  32. 32.
    1. Brittain-Long R,
    2. Westin J,
    3. Olofsson S,
    4. Lindh M,
    5. Andersson LM
    . Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial. BMC Med 2011;9:44.
  33. 33.
    1. Christakis DA,
    2. Zimmerman FJ,
    3. Wright JA,
    4. Garrison MM,
    5. Rivara FP,
    6. Davis RL
    . A randomized controlled trial of point-of-care evidence to improve the antibiotic prescribing practices for otitis media in children. Pediatrics 2001;107:E15.
  34. 34.
    1. Christakis DA,
    2. Wright JA,
    3. Taylor JA,
    4. Zimmerman FJ
    . Association between parental satisfaction and antibiotic prescription for children with cough and cold symptoms. Pediatr Infect Dis J 2005;24:774–7.
  35. 35.
    1. Dahler-Eriksen BS,
    2. Lauritzen T,
    3. Lassen JF,
    4. Lund ED,
    5. Brandslund I
    . Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem 1999;45:478–85.
  36. 36.
    1. de la Poza Abad M,
    2. Mas Dalmau G,
    3. Moreno Bakedano M,
    4. et al
    . Prescription strategies in acute uncomplicated respiratory infections: a randomized clinical trial. JAMA Intern Med 2016;176:21–9.
  37. 37.
    1. Hemkens LG,
    2. Saccilotto R,
    3. Reyes SL,
    4. et al
    . Personalized prescription feedback using routinely collected data to reduce antibiotic use in primary care: a randomized clinical trial. JAMA Intern Med 2017;177:176–83.
  38. 38.
    1. Samore MH,
    2. Bateman K,
    3. Alder SC,
    4. et al
    . Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA 2005;294:2305–14.
  39. 39.
    1. Gerber JS,
    2. Prasad PA,
    3. Fiks AG,
    4. et al
    . Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013;309:2345–52.
  40. 40.
    1. Gerber JS,
    2. Prasad PA,
    3. Fiks AG,
    4. et al
    . Durability of benefits of an outpatient antimicrobial stewardship intervention after discontinuation of audit and feedback. JAMA 2014;312:2569–70.
  41. 41.
    1. Gonzales R,
    2. Anderer T,
    3. McCulloch CE,
    4. et al
    . A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med 2013;173:267–73.
  42. 42.
    1. Jenkins TC,
    2. Irwin A,
    3. Coombs L,
    4. et al
    . Effects of clinical pathways for common outpatient infections on antibiotic prescribing. Am J Med 2013;126:327–35 e12.
  43. 43.
    1. Finkelstein JA,
    2. Davis RL,
    3. Dowell SF,
    4. et al
    . Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1–7.
  44. 44.
    1. Meeker D,
    2. Linder JA,
    3. Fox CR,
    4. et al
    . Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562–70.
  45. 45.
    1. Yang L,
    2. Liu C,
    3. Wang L,
    4. Yin X,
    5. Zhang X
    . Public reporting improves antibiotic prescribing for upper respiratory tract infections in primary care: a matched-pair cluster-randomized trial in China. Health Res Policy Syst 2014;12:61.
  46. 46.
    1. Schnoor M,
    2. Meyer T,
    3. Suttorp N,
    4. et al
    . Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care 2010;19:498–502.
  47. 47.
    1. Finkelstein JA,
    2. Huang SS,
    3. Kleinman K,
    4. et al
    . Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics 2008;121:e15–23.
  48. 48.
    1. Huang SS,
    2. Rifas-Shiman SL,
    3. Kleinman K,
    4. et al
    . Parental knowledge about antibiotic use: results of a cluster-randomized, multicommunity intervention. Pediatrics 2007;119:698–706.
  49. 49.
    1. Vervloet M,
    2. Meulepas MA,
    3. Cals JW,
    4. Eimers M,
    5. van der Hoek LS,
    6. van Dijk L
    . Reducing antibiotic prescriptions for respiratory tract infections in family practice: results of a cluster randomized controlled trial evaluating a multifaceted peer-group-based intervention. NPJ Prim Care Respir Med 2016;26:15083.
  50. 50.
    1. Linder JA,
    2. Schnipper JL,
    3. Tsurikova R,
    4. et al
    . Documentation-based clinical decision support to improve antibiotic prescribing for acute respiratory infections in primary care: a cluster randomised controlled trial. Inform Prim Care 2009;17:231–40.
  51. 51.
    1. Linder JA,
    2. Schnipper JL,
    3. Tsurikova R,
    4. et al
    . Electronic health record feedback to improve antibiotic prescribing for acute respiratory infections. Am J Manag Care 2010;16:e311–9.
  52. 52.
    1. Cals JW,
    2. Butler CC,
    3. Hopstaken RM,
    4. Hood K,
    5. Dinant GJ
    . Effect of point of care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338:b1374.
  53. 53.
    1. Cals JW,
    2. de Bock L,
    3. Beckers PJ,
    4. et al
    . Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann Fam Med 2013;11:157–64.
  54. 54.
    1. Mainous AG 3rd.,
    2. Lambourne CA,
    3. Nietert PJ
    . Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. J Am Med Inform Assoc 2013;20:317–24.
  55. 55.
    1. Slekovec C,
    2. Leroy J,
    3. Vernaz-Hegi N,
    4. et al
    . Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns. Int J Clin Pharm 2012;34:325–9.
  56. 56.
    1. Gonzales R,
    2. Corbett KK,
    3. Wong S,
    4. et al
    . “Get smart Colorado”: impact of a mass media campaign to improve community antibiotic use. Med Care 2008;46:597–605.
  57. 57.
    1. Hurlimann D,
    2. Limacher A,
    3. Schabel M,
    4. et al
    . Improvement of antibiotic prescription in outpatient care: a cluster-randomized intervention study using a sentinel surveillance network of physicians. J Antimicrob Chemother 2015;70:602–8.
  58. 58.
    1. Vinnard C,
    2. Linkin DR,
    3. Localio AR,
    4. et al
    . Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practices. Pop Health Mgmt 2013;16:22–7.
  59. 59.
    1. Gonzales R,
    2. Steiner JF,
    3. Lum A,
    4. Barrett PH Jr.
    . Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999;281:1512–9.
  60. 60.
    1. Gonzales R,
    2. Sauaia A,
    3. Corbett KK,
    4. et al
    . Antibiotic treatment of acute respiratory tract infections in the elderly: effect of a multidimensional educational intervention. J Am Geriatr Soc 2004;52:39–45.
  61. 61.
    1. Formoso G,
    2. Paltrinieri B,
    3. Marata AM,
    4. et al
    . Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ 2013;347:f5391.
  62. 62.
    1. Yardley L,
    2. Douglas E,
    3. Anthierens S,
    4. et al
    . Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial. Implement Sci 2013;8:134.
  63. 63.
    1. Szymczak JE,
    2. Feemster KA,
    3. Zaoutis TE,
    4. Gerber JS
    . Pediatrician perceptions of an outpatient antimicrobial stewardship intervention. Infect Control Hosp Epidemiol 2014;35:S69–78.
  64. 64.
    1. Mustafa M,
    2. Wood F,
    3. Butler CC,
    4. Elwyn G
    . Managing expectations of antibiotics for upper respiratory tract infections: a qualitative study. Ann Fam Med 2014;12:29–36.
  65. 65.
    1. Grondal H,
    2. Hedin K,
    3. Strandberg EL,
    4. Andre M,
    5. Brorsson A
    . Near-patient tests and the clinical gaze in decision-making of Swedish GPs not following current guidelines for sore throat—a qualitative interview study. BMC Fam Pract 2015;16:81.
  66. 66.
    1. Munoz-Plaza CE,
    2. Parry C,
    3. Hahn EE,
    4. et al
    . Integrating qualitative research methods into care improvement efforts within a learning health system: addressing antibiotic overuse. Health Res Policy Syst 2016;14:63.
  67. 67.
    1. Tonkin-Crine S,
    2. Yardley L,
    3. Coenen S,
    4. et al
    . Strategies to promote prudent antibiotic use: exploring the views of professionals who develop and implement guidelines and interventions. Fam Pract 2013;30:88–95.
  68. 68.
    1. Wood F,
    2. Phillips C,
    3. Brookes-Howell L,
    4. et al
    . Primary care clinicians' perceptions of antibiotic resistance: a multi-country qualitative interview study. J Antimicrob Chemother 2013;68:237–43.
  69. 69.
    1. Huddy JR,
    2. Ni MZ,
    3. Barlow J,
    4. Majeed A,
    5. Hanna GB
    . Point-of-care C reactive protein for the diagnosis of lower respiratory tract infection in NHS primary care: a qualitative study of barriers and facilitators to adoption. BMJ Open 2016;6:e009959.
  70. 70.
    1. Mauffrey V,
    2. Kivits J,
    3. Pulcini C,
    4. Boivin JM
    . Perception of acceptable antibiotic stewardship strategies in outpatient settings. Med Mal Infect 2016;46:285–93.
  71. 71.
    1. Ronnerstrand B,
    2. Andersson Sundell K
    . Trust, reciprocity and collective action to fight antibiotic resistance. An experimental approach. Soc Sci Med 2015;142:249–55.
  72. 72.
    1. Dempsey PP,
    2. Businger AC,
    3. Whaley LE,
    4. Gagne JJ,
    5. Linder JA
    . Primary care clinicians' perceptions about antibiotic prescribing for acute bronchitis: a qualitative study. BMC Fam Pract 2014;15:194.
  73. 73.
    1. Rowbotham S,
    2. Chisholm A,
    3. Moschogianis S,
    4. et al
    . Challenges to nurse prescribers of a no-antibiotic prescribing strategy for managing self-limiting respiratory tract infections. J Adv Nurs 2012;68:2622–32.
  74. 74.
    1. Kuzujanakis M,
    2. Kleinman K,
    3. Rifas-Shiman S,
    4. Finkelstein JA
    . Correlates of parental antibiotic knowledge, demand, and reported use. Ambul Pediatr 2003;3:203–10.
  75. 75.
    1. Ackerman SL,
    2. Gonzales R,
    3. Stahl MS,
    4. Metlay JP
    . One size does not fit all: evaluating an intervention to reduce antibiotic prescribing for acute bronchitis. BMC Health Serv Res 2013;13:462.
  76. 76.
    1. Murphy M,
    2. Bradley CP,
    3. Byrne S
    . Antibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing–an Irish perspective. BMC Fam Pract 2012;13:43.
  77. 77.
    1. Anthierens S,
    2. Tonkin-Crine S,
    3. Douglas E,
    4. et al
    . General practitioners' views on the acceptability and applicability of a web-based intervention to reduce antibiotic prescribing for acute cough in multiple European countries: a qualitative study prior to a randomised trial. BMC Fam Pract 2012;13:101.
  78. 78.
    1. Gurses AP,
    2. Seidl KL,
    3. Vaidya V,
    4. et al
    . Systems ambiguity and guideline compliance: a qualitative study of how intensive care units follow evidence-based guidelines to reduce healthcare-associated infections. Qual Saf Health Care 2008;17:351–9.
  79. 79.
    1. Pronovost PJ,
    2. Berenholtz SM,
    3. Goeschel CA,
    4. et al
    . Creating high reliability in health care organizations. Health Serv Res 2006;41:1599–617.
  80. 80.
    1. Timmel J,
    2. Kent PS,
    3. Holzmueller CG,
    4. Paine L,
    5. Schulick RD,
    6. Pronovost PJ
    . Impact of the Comprehensive Unit-based Safety Program (CUSP) on safety culture in a surgical inpatient unit. Jt Comm J Qual Patient Saf 2010;36:252–60.
  81. 81.
    1. Simpson KR,
    2. Knox GE,
    3. Martin M,
    4. George C,
    5. Watson SR
    . Michigan Health & Hospital Association Keystone Obstetrics: a statewide collaborative for perinatal patient safety in Michigan. Jt Comm J Qual Patient Saf 2011;37:544–52.
  82. 82.
    1. Wick EC,
    2. Hobson DB,
    3. Bennett JL,
    4. et al
    . Implementation of a surgical comprehensive unit-based safety program to reduce surgical site infections. J Am Coll Surg 2012;215:193–200.
  83. 83.
    1. Ali KJ,
    2. Farley DO,
    3. Speck K,
    4. Catanzaro M,
    5. Wicker KG,
    6. Berenholtz SM
    . Measurement of implementation components and contextual factors in a two-state healthcare quality initiative to reduce ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2014;35:S116–23.
  84. 84.
    1. Hsu YJ,
    2. Marsteller JA
    . Influence of the Comprehensive Unit-based Safety Program in ICUs: evidence from the Keystone ICU Project. Am J Med Qual 2016;31:349–57.

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire